TOVA CARAM: Open Payments
NPI 1912658428 · POUGHKEEPSIE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$249 in 7 payments from 6 companies in 2025. Trend: 2023 $930 · 2024 $787 · 2025 $249
Food & beverage: $249
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $128 |
| Supernus Pharmaceuticals, Inc. | 2 | $45 |
| Neurocrine BioSciences, Inc. | 1 | $25 |
| Axsome Therapeutics, Inc. | 1 | $21 |
| ABBVIE INC. | 1 | $16 |
| Lundbeck LLC | 1 | $14 |
Products named: CAPLYTA, Qelbree, INGREZZA, Auvelity, VRAYLAR, REXULTI.
Industry payments across NY — which companies pay providers there.
